Freshly IPO’d Tocagen tweaks brain cancer gene therapy test – FierceBiotech
FierceBiotech |
Freshly IPO’d Tocagen tweaks brain cancer gene therapy test
FierceBiotech The company got off an IPO in April worth $85 million toward its gene therapy tests, although it has lost value, going from $12.45 a share in mid-April to $9.23 yesterday, where it also closed down by more than 3%, and with a market cap of just over … Gene Therapy May Fight Brain Cancer’s ReturnWebMD Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancerSTAT Safety of gene therapy for brain tumours tested in early trialCancer Research UK Philly.com –Xconomy –Markets Insider all 7 news articles » |
Dayton Daily News |
Tri-service effort leverages synthetic biology expertise
Dayton Daily News Dr. Chia Hung discusses current research in the biology lab at the Air Force Research Laboratory’s Materials and Manufacturing directorate during a visit of members of the tri-service Applied Research for the Advancement of Science and Technology … |
|
Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancer
STAT rain cancer keeps popping up in the news for the wrong reasons. Last week, it took the life of Gord Downie, lead singer of the Canadian rock band The Tragically Hip. Sen. John McCain, who was diagnosed in July, recently acknowledged 1 his prognosis is … |